These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28830241)

  • 41. Impact of COVID-19 on psychoactive medication use among individuals with intellectual and developmental disabilities in Ontario, Canada: A repeated cross-sectional study.
    Guan Q; Garg R; McCormack D; Lunsky Y; Tadrous M; Campbell T; Gomes T
    Disabil Health J; 2024 Oct; 17(4):101649. PubMed ID: 38876963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Young People With Antipsychotic Medications in the United States.
    Olfson M; King M; Schoenbaum M
    JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Issues in the Medication Management Process in People Who Have Intellectual and Developmental Disabilities: A Qualitative Study of the Caregivers' Perspective.
    Erickson SR; Salgado TM; Tan X
    Intellect Dev Disabil; 2016 Dec; 54(6):412-426. PubMed ID: 27893313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychiatric comorbidity in patients with epilepsy: a population-based study.
    Karouni M; Arulthas S; Larsson PG; Rytter E; Johannessen SI; Landmark CJ
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1151-60. PubMed ID: 20669014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States.
    Park Y; Huybrechts KF; Cohen JM; Bateman BT; Desai RJ; Patorno E; Mogun H; Cohen LS; Hernandez-Diaz S
    Psychiatr Serv; 2017 Nov; 68(11):1112-1119. PubMed ID: 28617210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregnancy in Women With Intellectual and Developmental Disabilities.
    Brown HK; Lunsky Y; Wilton AS; Cobigo V; Vigod SN
    J Obstet Gynaecol Can; 2016 Jan; 38(1):9-16. PubMed ID: 26872750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study on the use of Antipsychotic Medication in an Intellectual Disability (ID) community caseload.
    Thalitaya MD; Reynolds C; Ismail I
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):578-583. PubMed ID: 28953833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study.
    Sheehan R; Horsfall L; Strydom A; Osborn D; Walters K; Hassiotis A
    BMJ Open; 2017 Aug; 7(8):e017406. PubMed ID: 28775195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rate of deficit accumulation in home care users with intellectual and developmental disabilities.
    Ouellette-Kuntz H; Martin L; McKenzie K
    Ann Epidemiol; 2018 Apr; 28(4):220-224. PubMed ID: 29433976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Balogh R; Wood J; Dobranowski K; Lin E; Wilton A; Jaglal SB; Gemmill M; Lunsky Y
    Osteoporos Int; 2017 Feb; 28(2):727-732. PubMed ID: 27613720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re: Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.
    Bradley EA; Lunsky Y; Berg JM; Brooks-Hill RW; O'Leary DA; Harman KE; Korossy M
    Can J Psychiatry; 2002 Oct; 47(8):785; author reply 785-6. PubMed ID: 12420658
    [No Abstract]   [Full Text] [Related]  

  • 52. The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities.
    Deb S; Sohanpal SK; Soni R; Lenôtre L; Unwin G
    J Intellect Disabil Res; 2007 Oct; 51(Pt 10):766-77. PubMed ID: 17803495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Organizational attributes of interprofessional primary care for adults with intellectual and developmental disabilities in ontario, Canada: a multiple case study.
    Bobbette N; Lysaght R; Ouellette-Kuntz H; Tranmer J; Donnelly C
    BMC Fam Pract; 2021 Jul; 22(1):157. PubMed ID: 34294044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using an accumulation of deficits approach to measure frailty in a population of home care users with intellectual and developmental disabilities: an analytical descriptive study.
    McKenzie K; Ouellette-Kuntz H; Martin L
    BMC Geriatr; 2015 Dec; 15():170. PubMed ID: 26678519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use.
    Matson JL; Fodstad JC; Neal D; Dempsey T; Rivet TT
    Res Dev Disabil; 2010; 31(1):108-16. PubMed ID: 19720497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those Without.
    Erickson SR; Kamdar N; Wu CH
    Am J Intellect Dev Disabil; 2020 Jan; 125(1):37-48. PubMed ID: 31877264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of antipsychotic prescriptions among patients with anxiety disorders treated in inpatient and outpatient psychiatric settings.
    Weber SR; Wehr AM; Duchemin AM
    J Affect Disord; 2016 Feb; 191():292-9. PubMed ID: 26688499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The uptake of secondary prevention by adults with intellectual and developmental disabilities.
    Ouellette-Kuntz H; Cobigo V; Balogh R; Wilton A; Lunsky Y
    J Appl Res Intellect Disabil; 2015 Jan; 28(1):43-54. PubMed ID: 25530573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Power of Partnerships to Identify and Address Mental Health Concerns Experienced by Adults With Intellectual and Developmental Disabilities.
    Lunsky Y; Lake J; Thakur A
    Am J Intellect Dev Disabil; 2024 Mar; 129(2):96-100. PubMed ID: 38411240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.